close

Clinical Trials

1 188 189 190
Number of results: 3789

Excel print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2011-01-07 4SC-203 1 4SC (Germany) Cancer Oncology
2011-01-03 Nalmefene alcohol dependence 3 Lundbeck (Denmark) CNS diseases
2010-11-01 galunisertib (LY2157299) hepatocellular carcinoma 2 Eli Lilly (USA - IN) Cancer - Oncology
2010-10-12 galunisertib glioma 1b-2a Eli Lilly (USA - IN) Cancer - Oncology
2008-03-05 aglatimagene besadenovec (AdV-tk) followed by valacyclovir glioma 1 Advantagene (USA - MA) Cancer - Oncology
2007-12-27 aglatimagene besadenovec (AdV-tk) followed by valacyclovir glioma 2a Advantagene (USA - MA) Cancer - Oncology
0000-00-00 ETS2101 (dexanabinol) Cancer - Oncology
0000-00-00 JNJ-54257099/AL-704 chronic hepatitits C 1 Alios Biopharma, a J&J company (USA - NJ) Janssen Pharmaceutica, a J&J company (USA - NJ) Infectious diseases
0000-00-00 PRX-102 (alpha-galactosidase-A) Fabry disease 3 Protalix BioTherapeutics (Israel) Rare diseases - Genetic diseases